Press release | Göteborg, Sweden | November 27, 2025 | Texray MasterPeace™ ERPD has been rigorously tested in a randomized controlled study. The results were presented at TCT, San Francisco, USA last month.

Dr. Oskar Angerås (Sahlgrenska University Hospital, Sweden) presented results from a unique study on Texray MasterPeace ERPD, at the TCT meeting in San Francisco, USA. It is the first randomized controlled trial of its kind, introducing a robust evaluation methodology for ERPD with the long-term objective of improving the work environment for healthcare professionals.¹ The abstract is published in the Journal of the American College of Cardiology (JACC).

“The results are encouraging and come from a well-structured evaluation. Data has an ideal way of revealing truths, especially when collected with a rigorous approach. Our aim was to evaluate how the system performs in everyday practice, and to understand) how new occupational safety measures might be responsible integrated, says Oskar Angerås, Interventional Cardiologist at Sahlgrenska University Hospital.

EXCELLENT SHIELDING EFFICACY DEMONSTRATED
In a randomized controlled 12-weeks evaluation, operators and nurses significantly reduced their radiation doses consistently over the legs, groin and torso areas demonstrating a clear improvement in staff protection.

“The shielding was highly effective yet enabled us to maintain our usual workflow. These results indicate that lighter personal radiation protection garments may be feasible when used together with next-generation ERPD systems such as MasterPeace,” says Dr. Truls Råmunddal Senior Interventional Cardiologist at Sahlgrenska University Hospital.

When extrapolated to a full working year (52 weeks), the reduction is substantial, MasterPeace ERPD users may see annual exposures as low as 0,9 mSv, emphasizing the system’s ability to significantly enhance radiation protection in clinical environments.²

“I am tremendously proud of the team behind the development of our textile-based ERPD. From day one, we have remained fully committed ensuring that when our product is put to the test, it stands firmly on evidence and measurable performance. We congratulate the team at Sahlgrenska University Hospital for conducting such a well-designed study with robust high-quality data, Says Petra Apell Founder & CEO at Texray.

ABOUT THE PRODUCT
Texray MasterPeace is a textile-based ERPD, allowing for unrestricted procedural access to maintain high quality of care to patients while maximizing radiation protection for the staff^2,3,4,. Engineered for simplicity and scalability, MasterPeace comprises a durable radiation attenuating textile, integrated into table-mounted shields and modular shields draped over the patient to form a seamless barrier between the staff and the radiation source. The malleable textile improves ergonomic adaptability, durability, and comfort, enhancing staff safety and workflow during fluoroscopically guided interventions.⁵

🟡

For more information on the Clinical evaluation please contact Dr. Oskar Angerås, Sahlgrenska University Hospital, Göteborg; Sweden

For more information on Texray MasterPeace ERPD please contact Nina Offen Lantz